VMD
Viemed Healthcare, Inc.
Price Chart
Latest Quote
$10.64
| Previous Close | $10.53 |
| Open | $10.64 |
| Day High | $10.68 |
| Day Low | $10.41 |
| Volume | 312,854 |
Stock Information
| Shares Outstanding | 38.34M |
| Total Debt | $12.44M |
| Cash Equivalents | $9.76M |
| Revenue | $286.56M |
| Net Income | $14.89M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $407.90M |
| P/E Ratio | 28.76 |
| EPS (TTM) | $0.37 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $400.24M |
| Sales | $286.56M |
| Income | $14.89M |
| Book/sh | $3.72 |
| Cash/sh | $0.25 |
| Employees | 1K |
Financial Ratios
| Quick Ratio | 1.01 |
| Current Ratio | 1.22 |
| Debt/Eq | 8.53 |
| EPS Growth TTM | -1.60% |
Returns & Margins
| ROA | 8.32% |
| ROE | 10.89% |
| Gross Margin | 57.58% |
| Operating Margin | 6.27% |
| Profit Margin | 5.20% |
Ownership
| Insider Ownership | 13.92% |
| Institutional Ownership | 69.63% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 26.60 |
| P/S | 1.42 |
| P/B | 2.86 |
Analyst Data
| Recommendation | none |
| Target Price | $11.00 |
Technical Indicators
| SMA20 | $10.00 |
| SMA50 | $9.72 |
| SMA200 | $8.08 |
| RSI | 71.28 |
| ATR | 0.3070 |
| Shares Float | 30.25M |
| Short Float | 1.52% |
| Short Ratio | 1.89 |
| Volatility | 1.13 |
| Rel Volume | 1.45 |
Performance History
| Week | +2.11% |
| Month | +10.72% |
| Quarter | +15.40% |
| 6 Months | +46.56% |
| YTD | +47.37% |
| Year | +61.21% |
| 3 Years | +7.37% |
| 5 Years | +41.68% |
| 10 Years | +51.57% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $10.64 | 324,700 |
| 2026-06-17 | $10.53 | 400,600 |
| 2026-06-16 | $10.32 | 392,000 |
| 2026-06-15 | $10.44 | 223,400 |
| 2026-06-12 | $10.45 | 200,400 |
| 2026-06-11 | $10.42 | 183,500 |
| 2026-06-10 | $10.13 | 167,200 |
| 2026-06-09 | $9.92 | 208,700 |
| 2026-06-08 | $9.92 | 220,600 |
| 2026-06-05 | $9.97 | 172,900 |
| 2026-06-04 | $9.84 | 172,500 |
| 2026-06-03 | $9.56 | 248,700 |
| 2026-06-02 | $9.48 | 166,100 |
| 2026-06-01 | $9.72 | 186,400 |
| 2026-05-29 | $9.84 | 278,700 |
| 2026-05-28 | $10.01 | 228,500 |
| 2026-05-27 | $9.89 | 189,400 |
| 2026-05-26 | $9.62 | 198,100 |
| 2026-05-22 | $9.65 | 174,200 |
| 2026-05-21 | $9.63 | 132,900 |
| 2026-05-20 | $9.68 | 216,200 |
| 2026-05-19 | $9.61 | 248,900 |
About Viemed Healthcare, Inc.
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
đ° Latest News
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
Motley Fool âĸ 2026-06-10T18:54:13ZUS Undiscovered Gems To Watch In May 2026
Simply Wall St. âĸ 2026-05-29T17:33:29ZTop Growth Companies With Significant Insider Ownership May 2026
Simply Wall St. âĸ 2026-05-27T17:36:09ZViemed Healthcare Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-07T08:18:18ZViemed Healthcare, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-06T12:30:00ZViemed Healthcare, Inc. (VMD) Q1 Earnings Miss Estimates
Zacks âĸ 2026-05-06T00:30:14Z3 Undiscovered Gems In The US Market To Watch
Simply Wall St. âĸ 2026-04-29T17:33:17ZThree Insider-Favored Growth Companies With High Ownership
Simply Wall St. âĸ 2026-04-28T17:35:58ZIf EPS Growth Is Important To You, Viemed Healthcare (NASDAQ:VMD) Presents An Opportunity
Simply Wall St. âĸ 2026-03-29T12:44:17ZViemed Healthcare Highlights Growth, Diversification and 2026 Guidance at Investor Conference
MarketBeat âĸ 2026-03-22T21:02:52ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $87,694,000 | $67,169,000 | $49,754,000 | $39,534,000 |
| Cost Of Revenue | $114,822,000 | $91,054,000 | $70,225,000 | $54,152,000 |
| Total Revenue | $270,280,000 | $224,257,000 | $183,008,000 | $138,832,000 |
| Operating Revenue | $270,280,000 | $224,257,000 | $183,008,000 | $138,832,000 |
| Expenses | ||||
| Interest Expense | $1,182,000 | $776,000 | $424,000 | $197,000 |
| Total Expenses | $249,570,000 | $208,262,000 | $168,033,000 | $130,234,000 |
| Other Income Expense | $2,239,000 | $951,000 | $-160,000 | $589,000 |
| Net Non Operating Interest Income Expense | $-1,182,000 | $-776,000 | $-424,000 | $-197,000 |
| Interest Expense Non Operating | $1,182,000 | $776,000 | $424,000 | $197,000 |
| Operating Expense | $134,748,000 | $117,208,000 | $97,808,000 | $76,082,000 |
| Other Operating Expenses | $-252,000 | $173,000 | $-98,000 | $-989,000 |
| General And Administrative Expense | $130,498,000 | $112,484,000 | $93,733,000 | $73,363,000 |
| Total Other Finance Cost | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $14,934,000 | $11,265,000 | $10,243,000 | $6,222,000 |
| Net Interest Income | $-1,182,000 | $-776,000 | $-424,000 | $-197,000 |
| Normalized Income | $13,353,266 | $10,593,594 | $10,356,920 | $6,461,432 |
| Net Income From Continuing And Discontinued Operation | $14,934,000 | $11,265,000 | $10,243,000 | $6,222,000 |
| Total Operating Income As Reported | $22,949,000 | $17,900,000 | $14,330,000 | $8,252,000 |
| Net Income Common Stockholders | $14,934,000 | $11,265,000 | $10,243,000 | $6,222,000 |
| Net Income | $14,934,000 | $11,265,000 | $10,243,000 | $6,222,000 |
| Net Income Including Noncontrolling Interests | $15,376,000 | $11,409,000 | $10,243,000 | $6,222,000 |
| Net Income Continuous Operations | $15,376,000 | $11,409,000 | $10,243,000 | $6,222,000 |
| Pretax Income | $21,767,000 | $16,170,000 | $14,391,000 | $8,990,000 |
| Special Income Charges | $2,239,000 | $1,905,000 | $-645,000 | $-346,000 |
| Operating Income | $20,710,000 | $15,995,000 | $14,975,000 | $8,598,000 |
| Depreciation Amortization Depletion Income Statement | $1,485,000 | $1,483,000 | $1,391,000 | $1,012,000 |
| Depreciation And Amortization In Income Statement | $1,485,000 | $1,483,000 | $1,391,000 | $1,012,000 |
| Gross Profit | $155,458,000 | $133,203,000 | $112,783,000 | $84,680,000 |
| Earnings From Equity Interest | - | $-954,000 | $485,000 | $935,000 |
| Depreciation Income Statement | - | - | - | $1,012,000 |
| Per Share | ||||
| Diluted EPS | $0.37 | $0.28 | $0.25 | $0.16 |
| Basic EPS | $0.38 | $0.29 | $0.27 | $0.16 |
| Other | ||||
| Tax Effect Of Unusual Items | $658,266 | $279,594 | $-46,080 | $-106,568 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $49,323,000 | $41,363,000 | $36,837,000 | $25,163,000 |
| Total Unusual Items | $2,239,000 | $951,000 | $-160,000 | $-346,000 |
| Total Unusual Items Excluding Goodwill | $2,239,000 | $951,000 | $-160,000 | $-346,000 |
| Reconciled Depreciation | $28,613,000 | $25,368,000 | $21,862,000 | $15,630,000 |
| EBITDA (Bullshit earnings) | $51,562,000 | $42,314,000 | $36,677,000 | $24,817,000 |
| EBIT | $22,949,000 | $16,946,000 | $14,815,000 | $9,187,000 |
| Diluted Average Shares | $40,823,823 | $40,805,085 | $40,378,922 | $39,807,434 |
| Basic Average Shares | $38,895,228 | $38,754,893 | $38,354,071 | $38,655,403 |
| Diluted NI Availto Com Stockholders | $14,934,000 | $11,265,000 | $10,243,000 | $6,222,000 |
| Minority Interests | $-442,000 | $-144,000 | $0 | $0 |
| Tax Provision | $6,391,000 | $4,761,000 | $4,148,000 | $2,768,000 |
| Gain On Sale Of Ppe | $2,239,000 | $1,905,000 | $-645,000 | $-346,000 |
| Research And Development | $3,017,000 | $3,068,000 | $2,782,000 | $2,696,000 |
| Selling General And Administration | $130,498,000 | $112,484,000 | $93,733,000 | $73,363,000 |
| Other Gand A | $121,366,000 | $106,199,000 | $87,884,000 | $68,161,000 |
| Salaries And Wages | $9,132,000 | $6,285,000 | $5,849,000 | $5,202,000 |
| Gain On Sale Of Security | - | $-954,000 | $485,000 | - |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $81,322,000 | $97,556,000 | $83,563,000 | $97,094,000 |
| Total Assets | $199,154,000 | $177,069,000 | $154,895,000 | $117,043,000 |
| Total Non Current Assets | $150,661,000 | $124,189,000 | $116,528,000 | $77,301,000 |
| Non Current Deferred Assets | $5,289,000 | $8,398,000 | $4,558,000 | $3,119,000 |
| Non Current Deferred Taxes Assets | $5,289,000 | $8,398,000 | $4,558,000 | $3,119,000 |
| Investmentin Financial Assets | $2,794,000 | $2,794,000 | $3,899,000 | $4,155,000 |
| Goodwill And Other Intangible Assets | $60,223,000 | $33,837,000 | $30,332,000 | $0 |
| Other Intangible Assets | $1,285,000 | $848,000 | $567,000 | - |
| Current Assets | $48,493,000 | $52,880,000 | $38,367,000 | $39,742,000 |
| Other Current Assets | $4,132,000 | $6,109,000 | $2,449,000 | $3,849,000 |
| Inventory | $5,047,000 | $4,320,000 | $4,628,000 | $3,574,000 |
| Receivables | $25,813,000 | $24,911,000 | $18,451,000 | $15,405,000 |
| Taxes Receivable | $227,000 | $0 | $0 | $26,000 |
| Accounts Receivable | $25,586,000 | $24,911,000 | $18,451,000 | $15,379,000 |
| Cash Cash Equivalents And Short Term Investments | $13,501,000 | $17,540,000 | $12,839,000 | $16,914,000 |
| Cash And Cash Equivalents | $13,501,000 | $17,540,000 | $12,839,000 | $16,914,000 |
| Cash Equivalents | $6,303,000 | $10,582,000 | $5,657,000 | $11,004,000 |
| Cash Financial | $7,198,000 | $6,958,000 | $7,182,000 | $5,910,000 |
| Other Non Current Assets | - | - | $887,000 | $1,590,000 |
| Allowance For Doubtful Accounts Receivable | - | - | $-11,100,000 | $-8,500,000 |
| Gross Accounts Receivable | - | - | $29,551,000 | $23,879,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $15,948,000 | $6,866,000 | $10,324,000 | $694,000 |
| Long Term Debt And Capital Lease Obligation | $13,655,000 | $5,596,000 | $8,318,000 | $199,000 |
| Long Term Debt | $11,291,000 | $3,589,000 | $6,002,000 | - |
| Current Debt And Capital Lease Obligation | $2,293,000 | $1,270,000 | $2,006,000 | $495,000 |
| Current Debt | $1,090,000 | $409,000 | $1,072,000 | - |
| Other Current Borrowings | $1,090,000 | $409,000 | $1,072,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $55,633,000 | $43,768,000 | $41,000,000 | $19,949,000 |
| Total Non Current Liabilities Net Minority Interest | $14,577,000 | $6,442,000 | $8,876,000 | $1,088,000 |
| Current Liabilities | $41,056,000 | $37,326,000 | $32,124,000 | $18,861,000 |
| Other Current Liabilities | $1,650,000 | $1,701,000 | $1,867,000 | $1,704,000 |
| Current Deferred Liabilities | $7,520,000 | $6,694,000 | $6,207,000 | $4,624,000 |
| Payables And Accrued Expenses | $24,947,000 | $24,259,000 | $19,986,000 | $10,554,000 |
| Payables | $18,163,000 | $20,837,000 | $17,488,000 | $9,220,000 |
| Other Payable | $5,835,000 | $7,616,000 | $7,925,000 | $4,316,000 |
| Total Tax Payable | $0 | $3,883,000 | $2,153,000 | $0 |
| Income Tax Payable | $0 | $3,883,000 | $2,153,000 | $0 |
| Accounts Payable | $12,328,000 | $9,338,000 | $7,410,000 | $4,904,000 |
| Equity | ||||
| Common Stock Equity | $141,545,000 | $131,393,000 | $113,895,000 | $97,094,000 |
| Total Equity Gross Minority Interest | $143,521,000 | $133,301,000 | $113,895,000 | $97,094,000 |
| Stockholders Equity | $141,545,000 | $131,393,000 | $113,895,000 | $97,094,000 |
| Retained Earnings | $102,891,000 | $89,691,000 | $79,495,000 | $69,846,000 |
| Gains Losses Not Affecting Retained Earnings | - | - | - | $0 |
| Long Term Equity Investment | - | - | - | $2,155,000 |
| Other | ||||
| Ordinary Shares Number | $38,019,082 | $39,132,897 | $38,506,161 | $38,049,739 |
| Share Issued | $38,019,082 | $39,132,897 | $38,506,161 | $38,049,739 |
| Tangible Book Value | $81,322,000 | $97,556,000 | $83,563,000 | $97,094,000 |
| Invested Capital | $153,926,000 | $135,391,000 | $120,969,000 | $97,094,000 |
| Working Capital | $7,437,000 | $15,554,000 | $6,243,000 | $20,881,000 |
| Capital Lease Obligations | $3,567,000 | $2,868,000 | $3,250,000 | $694,000 |
| Total Capitalization | $152,836,000 | $134,982,000 | $119,897,000 | $97,094,000 |
| Minority Interest | $1,976,000 | $1,908,000 | $0 | - |
| Additional Paid In Capital | $21,742,000 | $18,337,000 | $15,698,000 | $12,125,000 |
| Capital Stock | $16,912,000 | $23,365,000 | $18,702,000 | $15,123,000 |
| Common Stock | $16,912,000 | $23,365,000 | $18,702,000 | $15,123,000 |
| Non Current Accrued Expenses | $922,000 | $846,000 | $558,000 | $889,000 |
| Long Term Capital Lease Obligation | $2,364,000 | $2,007,000 | $2,316,000 | $199,000 |
| Current Deferred Revenue | $7,520,000 | $6,694,000 | $6,207,000 | $4,624,000 |
| Current Capital Lease Obligation | $1,203,000 | $861,000 | $934,000 | $495,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $4,646,000 | $3,402,000 | $2,058,000 | $1,484,000 |
| Current Accrued Expenses | $6,784,000 | $3,422,000 | $2,498,000 | $1,334,000 |
| Investments And Advances | $2,794,000 | $2,794,000 | $3,899,000 | $4,155,000 |
| Available For Sale Securities | $2,794,000 | $2,794,000 | $3,899,000 | $4,155,000 |
| Goodwill | $58,938,000 | $32,989,000 | $29,765,000 | $0 |
| Net PPE | $82,355,000 | $79,160,000 | $76,852,000 | $68,437,000 |
| Accumulated Depreciation | $-60,920,000 | $-58,003,000 | $-52,937,000 | $-39,899,000 |
| Gross PPE | $143,275,000 | $137,163,000 | $129,789,000 | $108,336,000 |
| Leases | $717,000 | $660,000 | $345,000 | $296,000 |
| Other Properties | $124,887,000 | $119,819,000 | $114,193,000 | $94,587,000 |
| Machinery Furniture Equipment | $6,613,000 | $5,811,000 | $4,732,000 | $3,844,000 |
| Buildings And Improvements | $8,492,000 | $8,307,000 | $7,953,000 | $7,043,000 |
| Land And Improvements | $2,566,000 | $2,566,000 | $2,566,000 | $2,566,000 |
| Properties | $0 | $0 | $0 | $0 |
| Treasury Shares Number | - | - | $0 | - |
| Inventories Adjustments Allowances | - | - | - | $0 |
| Other Inventories | - | - | - | $3,574,000 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $11,931,000 | $1,318,000 | $19,119,000 | $4,850,000 |
| Operating Activities | ||||
| Operating Cash Flow | $51,916,000 | $39,089,000 | $45,212,000 | $27,748,000 |
| Cash Flow From Continuing Operating Activities | $51,916,000 | $39,089,000 | $45,212,000 | $27,748,000 |
| Operating Gains Losses | $-2,239,000 | $-2,166,000 | $160,000 | $-589,000 |
| Investing Activities | ||||
| Capital Expenditure | $-39,985,000 | $-37,771,000 | $-26,093,000 | $-22,898,000 |
| Investing Cash Flow | $-50,166,000 | $-30,699,000 | $-52,113,000 | $-23,976,000 |
| Cash Flow From Continuing Investing Activities | $-50,166,000 | $-30,699,000 | $-52,113,000 | $-23,976,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-14,959,000 | $-1,069,000 | $-594,000 | $-9,711,000 |
| Financing Cash Flow | $-5,789,000 | $-3,689,000 | $2,826,000 | $-15,266,000 |
| Cash Flow From Continuing Financing Activities | $-5,789,000 | $-3,689,000 | $2,826,000 | $-15,266,000 |
| Net Other Financing Charges | $-489,000 | $-228,000 | - | - |
| Net Common Stock Issuance | $-14,959,000 | $-1,069,000 | $-594,000 | $-9,711,000 |
| Dividend Received Cfo | $0 | $147,000 | $980,000 | $1,079,000 |
| Other | ||||
| Repayment Of Debt | $-13,780,000 | $-6,409,000 | $-10,883,000 | $-5,838,000 |
| Issuance Of Debt | $22,000,000 | $3,000,000 | $13,000,000 | $0 |
| Interest Paid Supplemental Data | $874,000 | $950,000 | $851,000 | $231,000 |
| Income Tax Paid Supplemental Data | $7,390,000 | $6,827,000 | $3,566,000 | - |
| End Cash Position | $13,501,000 | $17,540,000 | $12,839,000 | $16,914,000 |
| Beginning Cash Position | $17,540,000 | $12,839,000 | $16,914,000 | $28,408,000 |
| Changes In Cash | $-4,039,000 | $4,701,000 | $-4,075,000 | $-11,494,000 |
| Proceeds From Stock Option Exercised | $1,439,000 | $1,017,000 | $1,303,000 | $283,000 |
| Common Stock Payments | $-14,959,000 | $-1,069,000 | $-594,000 | $-9,711,000 |
| Net Issuance Payments Of Debt | $8,220,000 | $-3,409,000 | $2,117,000 | $-5,838,000 |
| Net Long Term Debt Issuance | $8,220,000 | $-3,409,000 | $2,117,000 | $-5,838,000 |
| Long Term Debt Payments | $-13,780,000 | $-6,409,000 | $-10,883,000 | $-5,838,000 |
| Long Term Debt Issuance | $22,000,000 | $3,000,000 | $13,000,000 | $0 |
| Net Investment Purchase And Sale | $0 | $750,000 | $0 | $-2,000,000 |
| Sale Of Investment | $0 | $750,000 | $0 | $0 |
| Net Business Purchase And Sale | $-26,332,000 | $-3,999,000 | $-28,608,000 | $-141,000 |
| Purchase Of Business | $-26,332,000 | $-3,999,000 | $-28,608,000 | $-141,000 |
| Net PPE Purchase And Sale | $-23,834,000 | $-27,450,000 | $-23,505,000 | $-21,835,000 |
| Sale Of PPE | $16,151,000 | $10,321,000 | $2,588,000 | $1,063,000 |
| Purchase Of PPE | $-39,985,000 | $-37,771,000 | $-26,093,000 | $-22,898,000 |
| Change In Working Capital | $-2,303,000 | $355,000 | $7,776,000 | $-124,000 |
| Change In Other Working Capital | $-3,751,000 | $2,094,000 | $3,030,000 | $2,738,000 |
| Change In Payables And Accrued Expense | $734,000 | $3,216,000 | $4,100,000 | $2,231,000 |
| Change In Accrued Expense | $255,000 | $2,857,000 | $4,959,000 | $2,549,000 |
| Change In Payable | $479,000 | $359,000 | $-859,000 | $-318,000 |
| Change In Account Payable | $479,000 | $359,000 | $-859,000 | $-318,000 |
| Change In Prepaid Assets | $-503,000 | $544,000 | $2,176,000 | $-2,838,000 |
| Change In Inventory | $59,000 | $574,000 | $-472,000 | $301,000 |
| Change In Receivables | $1,158,000 | $-6,073,000 | $-1,058,000 | $-2,556,000 |
| Changes In Account Receivables | $1,158,000 | $-6,073,000 | $-1,058,000 | $-2,556,000 |
| Other Non Cash Items | $228,000 | $1,531,000 | $-219,000 | - |
| Stock Based Compensation | $9,132,000 | $6,285,000 | $5,849,000 | $5,202,000 |
| Deferred Tax | $3,109,000 | $-3,840,000 | $-1,439,000 | $1,746,000 |
| Deferred Income Tax | $3,109,000 | $-3,840,000 | $-1,439,000 | $1,746,000 |
| Depreciation Amortization Depletion | $28,613,000 | $25,368,000 | $21,862,000 | $15,630,000 |
| Depreciation And Amortization | $28,613,000 | $25,368,000 | $21,862,000 | $15,630,000 |
| Depreciation | $28,613,000 | $25,368,000 | $21,862,000 | $15,630,000 |
| Earnings Losses From Equity Investments | $0 | $-261,000 | $-485,000 | $-935,000 |
| Gain Loss On Sale Of PPE | $-2,239,000 | $-1,905,000 | $645,000 | $346,000 |
| Net Income From Continuing Operations | $15,376,000 | $11,409,000 | $10,243,000 | $6,222,000 |
| Purchase Of Investment | - | $0 | $-20,000 | $-2,000,000 |
| Provisionand Write Offof Assets | - | $0 | $0 | $-1,418,000 |
| Net Short Term Debt Issuance | - | - | $995,000 | $0 |
| Short Term Debt Payments | - | - | $-7,005,000 | $0 |
| Short Term Debt Issuance | - | - | $8,000,000 | $0 |